The 2023 Florida Statutes (including Special Session C)
|
||||||
|
. . . conformity with, current good manufacturing practices to assure that the drug meets the requirements of ss. 499.001 . . . the facility to hold, process or package the drugs do not conform with the requirements of section 499.001 . . . facts demonstrate that the facilities and methods used did not conform to the requirements of section 499.001 . . .
. . . . §§ 499.001 et seq., which was enacted to “provide uniform legislation to be administered so far as . . .
. . . . §§ 499.001-499.081, and the Florida Deceptive and Unfair Trade Practices Act, Fla. . . . Section 499.002 provides that the Florida Department of Health “shall administer and enforce [§§ 499.001 . . .
. . . to maintain records that truthfully reflect its acquisition of prescription drugs as required by ss. 499.001 . . .
. . . Count VII alleges that the defendant violated Florida’s Drug and Cosmetics Act [§§ 499.001-499.081, FlaStat . . .
. . . . §§ 499.001-499.79 (West 1988). . . .